Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/10428194.2018.1482546 | DOI Listing |
Publication Analysis
Top Keywords
vigilance ibrutinib-associated
4
ibrutinib-associated ventricular
4
ventricular arrhythmias
4
arrhythmias rare
4
rare aware
4
vigilance
1
ventricular
1
arrhythmias
1
rare
1
aware
1
Similar Publications
Patterns of use and safety of ibrutinib in real-life practice.
Br J Clin Pharmacol
March 2021
Pharmacologie Clinique et Vigilances, CHU de Poitiers, Poitiers, France.
Article Synopsis
- The study aimed to gather real-life data on how ibrutinib is used and its safety profiles in patients between November 2014 and November 2018.
- A total of 102 patients participated, mainly receiving ibrutinib for chronic lymphocytic leukemia (CLL), with 47.1% experiencing serious adverse drug reactions (SADRs) within the first year.
- The findings highlighted that older patients (aged ≥80) and those with CLL had a higher risk of developing SADRs, indicating that they require closer monitoring during treatment.
Vigilance for ibrutinib-associated ventricular arrhythmias: rare but be aware.
Leuk Lymphoma
December 2018
b CLL Center, Dana Farber Cancer Institute, Boston , MA , USA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!